AI Diagnostic Tool Analyzes CT Scans to Spot Prostate Cancer Before Patients Have Symptoms
|
By MedImaging International staff writers Posted on 13 Jul 2021 |
|
Image: AI Diagnostic Tool Analyzes CT Scans to Spot Prostate Cancer Before Patients Have Symptoms (Photo courtesy of RMIT University)
Researchers have developed a diagnostic tool that can spot prostate cancer before patients have any symptoms, using artificial intelligence to analyze Computed Tomography (CT) scans in just seconds.
Researchers at RMIT University (Melbourne, Australia), in collaboration with clinicians at St Vincent’s Hospital Melbourne (Australia), have developed an artificial intelligence (AI) program that could catch the prostate cancer earlier, allowing for incidental detection through routine CT scans. The technology works by analyzing CT scans for tell-tale signs of prostate cancer, something even a well-trained human eye struggles to do.
Prostate cancer is the most diagnosed cancer and is slow growing, usually detected incidentally due to which it can go undiagnosed for years. It was responsible for an estimated 12% of male cancer deaths in 2020. Early detection is the key to successful treatment but men often dodge the doctor, avoiding diagnosis tests until it’s too late. CT imaging is not suitable for regular cancer screening because of the high radiation doses involved. CT scans were great for detecting bone and joint problems but even radiologists struggled to spot prostate cancers on the images. The new AI solution can be used to run a cancer check whenever men have their abdomen or pelvis scanned for other issues.
For the study, the researchers studied CT scans of asymptomatic patients, with and without prostate cancer. The team trained the AI software to look for features of disease in a variety of scans and where exactly to look for them, avoiding the need to manually crop the images. The AI performed better than radiologists who viewed the same images, detecting cancerous growths in just seconds. What’s more, the AI improved with each scan, learning and adapting to read images from different machines to spot even the smallest irregularities. The technology can be applied at scale, potentially integrating with a variety of diagnostic imaging equipment like MRI and DEXA machines - pending further research.
“We’ve trained our software to see what the human eye can’t, with the aim of spotting prostate cancer through incidental detection,” said RMIT’s Dr. Ruwan Tennakoon. “It’s like training a sniffer dog – we can teach the AI to see things that we can't with our own eyes, in the same way a dog can smell things human noses can’t.”
Related Links:
RMIT University
St Vincent’s Hospital Melbourne
Researchers at RMIT University (Melbourne, Australia), in collaboration with clinicians at St Vincent’s Hospital Melbourne (Australia), have developed an artificial intelligence (AI) program that could catch the prostate cancer earlier, allowing for incidental detection through routine CT scans. The technology works by analyzing CT scans for tell-tale signs of prostate cancer, something even a well-trained human eye struggles to do.
Prostate cancer is the most diagnosed cancer and is slow growing, usually detected incidentally due to which it can go undiagnosed for years. It was responsible for an estimated 12% of male cancer deaths in 2020. Early detection is the key to successful treatment but men often dodge the doctor, avoiding diagnosis tests until it’s too late. CT imaging is not suitable for regular cancer screening because of the high radiation doses involved. CT scans were great for detecting bone and joint problems but even radiologists struggled to spot prostate cancers on the images. The new AI solution can be used to run a cancer check whenever men have their abdomen or pelvis scanned for other issues.
For the study, the researchers studied CT scans of asymptomatic patients, with and without prostate cancer. The team trained the AI software to look for features of disease in a variety of scans and where exactly to look for them, avoiding the need to manually crop the images. The AI performed better than radiologists who viewed the same images, detecting cancerous growths in just seconds. What’s more, the AI improved with each scan, learning and adapting to read images from different machines to spot even the smallest irregularities. The technology can be applied at scale, potentially integrating with a variety of diagnostic imaging equipment like MRI and DEXA machines - pending further research.
“We’ve trained our software to see what the human eye can’t, with the aim of spotting prostate cancer through incidental detection,” said RMIT’s Dr. Ruwan Tennakoon. “It’s like training a sniffer dog – we can teach the AI to see things that we can't with our own eyes, in the same way a dog can smell things human noses can’t.”
Related Links:
RMIT University
St Vincent’s Hospital Melbourne
Computed Tomography System
Aquilion ONE / INSIGHT Edition
Multi-Use Ultrasound Table
Clinton
Ultrasound Table
Women’s Ultrasound EA Table
Mammo DR Retrofit Solution
DR Retrofit Mammography
Latest Industry News News
- Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
- GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
- Patient-Specific 3D-Printed Phantoms Transform CT Imaging
- Siemens and Sectra Collaborate on Enhancing Radiology Workflows
- Bracco Diagnostics and ColoWatch Partner to Expand Availability CRC Screening Tests Using Virtual Colonoscopy
- Mindray Partners with TeleRay to Streamline Ultrasound Delivery
- Philips and Medtronic Partner on Stroke Care
- Siemens and Medtronic Enter into Global Partnership for Advancing Spine Care Imaging Technologies
- RSNA 2024 Technical Exhibits to Showcase Latest Advances in Radiology
- Bracco Collaborates with Arrayus on Microbubble-Assisted Focused Ultrasound Therapy for Pancreatic Cancer
- Innovative Collaboration to Enhance Ischemic Stroke Detection and Elevate Standards in Diagnostic Imaging
- RSNA 2024 Registration Opens
- Microsoft collaborates with Leading Academic Medical Systems to Advance AI in Medical Imaging
- GE HealthCare Acquires Intelligent Ultrasound Group’s Clinical Artificial Intelligence Business
- Bayer and Rad AI Collaborate on Expanding Use of Cutting Edge AI Radiology Operational Solutions
- Polish Med-Tech Company BrainScan to Expand Extensively into Foreign Markets
Channels
Radiography
view channel
New Contrast Agent Enables Low-Dose X-Ray Joint Imaging
X-ray imaging offers limited visualization of soft tissues like cartilage, complicating evaluation of joint pain and degenerative disease. Clinicians often rely on joint-space narrowing as a proxy for... Read more
AI Boosts Breast Cancer Detection and Cuts Screening Workload
Breast cancer screening programs face rising demand and persistent workforce shortages, straining double-reading workflows and delaying care. Early detection is critical to reduce mortality and minimize... Read more
MRI
view channel
MRI Tool Enables Long-Term Tracking of Transplanted Cardiac Cells
Cell therapies for myocardial injury face a persistent hurdle: clinicians cannot easily monitor whether transplanted cells survive and where they persist in the heart. This limits optimization of dosing,... Read more
MRI-Based AI Tool Supports Differentiation of Parkinsonian Syndromes
Clinicians often struggle to differentiate Parkinsonian syndromes at initial presentation, when symptom overlap can obscure disease trajectory and delay targeted care. Imaging markers derived from diffusion... Read more
MRI-Derived Biomarker Improves Risk Stratification in Glioblastoma
Glioblastoma is marked by rapid growth and diffuse infiltration that complicate prognosis and treatment planning. Clinicians need objective tools that capture both how these tumors expand and how they... Read more
Combined Imaging Approach Identifies Cause of Heart Attack without Coronary Blockage
Patients who present with myocardial infarction but show no obstructive coronary disease often leave without a definitive diagnosis. That uncertainty complicates in-hospital decision-making and post-discharge... Read moreUltrasound
view channel
New Ultrasound AI Tool Supports Rapid Prenatal Assessment
Accurate gestational age estimation guides prenatal screening, detection of complications, and timely intervention. Access to ultrasound and trained sonographers is uneven, with nearly half of U.... Read more
New Consensus Standardizes Ultrasound-Based Fatty Liver Assessment
Metabolic dysfunction-associated steatotic liver disease (MASLD) is rising along with obesity and diabetes, making accurate, scalable measurement of hepatic fat a clinical priority. Biopsy is invasive... Read more
Nuclear Medicine
view channel
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more
General/Advanced Imaging
view channel
AI Tool Predicts Side Effects from Lung Cancer Treatment
Radiation therapy is a central treatment for lung cancer, but even carefully targeted radiation can affect surrounding healthy tissue. Patients may develop side effects such as lung inflammation, coughing,... Read more
AI Tool Offers Prognosis for Patients with Head and Neck Cancer
Oropharyngeal cancer is a form of head and neck cancer that can spread through lymph nodes, significantly affecting survival and treatment decisions. Current therapies often involve combinations of surgery,... Read more
Imaging IT
view channel
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
